Global Project on Anti-Tuberculosis Drug Resistance Surveillance

”In 1994, due to lack of standardized data on anti-TB drug resistance and in an effort to estimate the global prevalence of resistance, WHO, International Union Against Tuberculosis and Lung Disease (IUATLD) and other partners developed the Global Project on Anti-tuberculosis Drug Resistance Surveillance  (DRS).

The project assembled a network of Supranational Reference Laboratories (SRLN- Supranational Laboratory Network) to aid National Reference Laboratories in conducting quality assured drug susceptibility testing in conjunction with national or area anti-TB drug resistance surveillance. The project is now expanding implementation of surveys to new countries prioritizing countries with a high burden of TB, or suspected high prevalence of MDR, incorporating more rigorous surveillance of retreatment cases to determine prevalent resistance patterns, repeating surveys every three to five years in order to observe trends, and expanding objectives of surveillance to include operational research where capacity has been demonstrated.”

Source: The WHO/IUATLD Global Project on Drug Resistance Surveillance 

Drug resistance - International Union Against Tuberculosis and Lung Disease (IUATLD) - SRLN - Tuberculosis

GreenFacts Summary on Drug-resistant Tuberculosis:

• 2. What is the Global Project on Anti-tuberculosis Drug Resistance Surveillance?

Español: Proyecto global de vigilancia de la resistencia a los fármacos antituberculosos
Français: Projet mondial de surveillance de la résistance aux médicaments antituberculeux
Nederlands: Global Project on Anti-Tuberculosis Drug Resistance Surveillance

Tuberculosis